Featured Research

from universities, journals, and other organizations

The Smoking Gun: Elastin Fragments Drive Emphysema

Date:
February 11, 2006
Source:
Journal of Clinical Investigation
Summary:
Researchers at Harvard Medical School in Massachusetts have prevented emphysema in mice exposed to cigarette smoke by treating them with an antibody against lung elastin fragments. The fragments result from the lung-damaging activity of special enzymes called elastases, and stimulate migration of inflammatory cells into the lung. The study, which appears in the March issue of the JCI, suggests that blocking these chemotactic products of elastase activity can reduce inflammation and emphysema in smokers.

Pulmonary emphysema is caused primarily by cigarette smoking, and the underlying cellular mechanisms are thought to involve smoke-induced activation of tissue degrading enzymes known as proteases. Elastases are proteases that specifically degrade the structural protein elastin and include enzymes such as MMP-12 (matrix metalloproteinase -12, also called macrophage metalloelastase), which is secreted by inflammatory cells called macrophages.

Now, researcher A. McGarry Houghton and colleagues at Harvard Medical School in Massachusetts, report that elastases cause emphysema in mice through the generation of pro-inflammatory elastin fragments.

The study appears online on February 9 in advance of print publication in the March issue of the Journal of Clinical Investigation. The authors found that mice that had inhaled pancreatic elastase or who were exposed to cigarette smoke developed elastin fragments in their lungs, macrophage accumulation, and emphysema. However, when the researchers blocked the activity of elastin fragments using a specific anti-elastin antibody, the macrophage numbers were reduced, and the emphysema was prevented in both models. Using cultured human monocytes (macrophage precursor cells), the authors demonstrate that elastin fragments are chemotactic, meaning that they are able to attract inflammatory cells.

The studies suggest that the degradation products of protease activity, in addition to the proteases themselves, may be promising targets for emphysema therapy.

###

TITLE: Elastin fragments drive disease progression in a murine model of emphysema

View the PDF of this article at: https://www.the-jci.org/article.php?id=25617


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "The Smoking Gun: Elastin Fragments Drive Emphysema." ScienceDaily. ScienceDaily, 11 February 2006. <www.sciencedaily.com/releases/2006/02/060211135146.htm>.
Journal of Clinical Investigation. (2006, February 11). The Smoking Gun: Elastin Fragments Drive Emphysema. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2006/02/060211135146.htm
Journal of Clinical Investigation. "The Smoking Gun: Elastin Fragments Drive Emphysema." ScienceDaily. www.sciencedaily.com/releases/2006/02/060211135146.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins